crohn’s & colitis foundation visiting ibd · crohn’s & colitis foundation visiting ibd...

Crohn’s & Colitis Foundation Visiting IBD Fellowship 2018-2019 Professional Education Resources & Reading List 2018

Virtual Preceptorship …………………… 1

ReachMD Resources ……………………. 2

Biosimilars Resources ……………………3

Professional Reading list ………………..4 - 6

VIRTUAL PRECEPTORSHIP (Online Accredited Interactive Case Modules)

IBD in Clinical Practice: Malnutrition Update for Healthcare Providers

In this CME online activity, you will learn the importance of malnutrition for IBD patients and how to apply important elements of the Foundation’s IBD Nutrition Care Pathway -- a tool that is useful for the screening, evaluation, intervention, and monitoring for patients with IBD and malnutrition.

This activity is jointly provided by Postgraduate Institute for Medicine, the Crohn's & Colitis Foundation, and RMEI Medical Education, LLC. This activity is supported by an independent medical educational grant from Nestlé Health Science.

IBD in Clinical Practice: Anemia

In this CME online activity you will learn how to apply important elements of the Foundation’s IBD Anemia Care Pathway -- a tool that is useful for the screening, evaluation, intervention, and follow up of patients with IBD and iron deficiency. Also in this activity you will hear a testimonial from Lyn, an IBD patient with iron deficiency, as she recounts interesting aspects of her history and treatments.

This activity is jointly provided by Postgraduate Institute for Medicine, the Crohn's & Colitis Foundation, and RMEI Medical Education, LLC. This activity is supported by an independent medical educational grant form Luitpold Pharmaceuticals.

1

http://crohnscolitisfoundation.realcme.com/cms/node/764609

http://crohnscolitisfoundation.realcme.com/cms/node/725331?utm_source=activitylist&utm_medium=web&utm_content=all&utm_campaign=

http://crohnscolitisfoundation.realcme.com/cms/node/725331?utm_source=activitylist&utm_medium=web&utm_content=all&utm_campaign=

New Educational Resources for Healthcare ProfessionalsThe Crohn’s & Colitis Foundation has partnered with ReachMD, the nation’s largest medical education learning platform for healthcare professionals, to deliver exclusive IBD content. Watch expert interviews on IBD topics through the Crohn’s & Colitis Perspectives educational series, and listen to short audio distillations of articles from the Inflammatory Bowel Diseases Journal through ReachMD’s AudioAbstracts™.

Access these great resources at:ReachMD.com/Foundation

reachmd.indd 1 11/9/2017 2:18:29 PM

2

Comprehensive Update of Biosimilar TherapiesThe Crohn’s & Colitis Foundation and American Gastroenterological Association (AGA) are pleased to provide several CME educational resources for professionals to ensure accurate and unbiased infor-mation about biosimilars. This program is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc.

On-demand Online Activities:CME Video Advent of Biosimilar Products in US GI Practice— learn how biosimilars are used in the practice of gastroenterology in the US CME Video Consideration in the Use of Biosimilars for Gastrointestinal Disorders— overview of the current body of knowledge on the safety and efficacy of biosimilar products, pricing and impact of payor decisions on clinical GI practice CME Video Talking to your IBD Patient about Biosimilar Therapies—best practices for how to converse with patients on biosimilars CME Module U.S. FDA Regulatory Pathway for Biosimilars—an overview of how biosimilars are licensed in the U.S., exploring interchangeability and data extrapolation

Webcast Comprehensive Update of Biosimilar Therapies: Your Questions Answered—updates on biosimilars from Dr. Gary R. Lichtenstein and engaging interactive panel with Drs. Brian G. Feagan, David T. Rubin and a patient

Access and learn more at: www.crohnscolitisfoundation.org/science-and-professionals/biosimilars.html

3

Professional Reading List 2018

Section: Practice Guidelines

Gastroenterology. 2015 May; 148 (5):1035-1058.e3. Clinical Practice Guidelines for the Medical Management of Nonhospital zed Ulcerative Colitis: The Toronto Consensus Bressler B1, Marshall JK2, Bernstein CN3, Bitton A4, Jones J5, Leontiadis GI2, Panaccione R6, Steinhart AH7, Tse F2, Feagan B8;

Journal of Crohn's & Colitis. 2012;6(10):991-1030. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M et al

Section: Treatment Strategies Clinical Gastroenterol Hepatology. 2015 Jun;13(6):1042-1050.e2. Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease. Bouguen G1, Levesque BG2, Feagan BG3, Kavanaugh A4, Peyrin-Biroulet L5, Colombel JF6, Hanauer SB7, Sandborn WJ8.

Gut. 2013 Nov; 62(11):1523-8. The management of immunosuppression in patients with inflammatory bowel disease and cancer. Bernheim O1, Colombel JF, Ullman TA, Laharie D, Beaugerie L, Itzkowitz SH.

Gut. 2012 Feb; 61(2):229-34. Switch to adalimumab in patients with Crohn’s disease controlled by maintenance infliximab: prospective randomized SWITCH trial. Van Assche G1, Vermeire S, Ballet V, Gabriels F, Noman M, D'Haens G, Claessens C, Humblet E, Vande Casteele N, Gils A, Rutgeerts P.

Section: Treatment/Biologics N Engl J Med. 2013 Aug 22; 369(8):711-21. Vedolizumab as induction and maintenance therapy for Crohn's disease. Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S,Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group.

Gut. 2014;63(3):433-41. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Travis SP, Danese S, Kupcinskas L, Alexeeva O, D'Haens G, Gibson PR et al.

The New England journal of medicine. 2005;353(23):2462-76. Infliximab for induction and maintenance therapy for ulcerative colitis. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J et al.

Gastroenterology. 2014;146(2):392-400 e3. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Panaccione R, Ghosh S, Middleton S, Marquez JR, Scott BB, Flint L et al.

Gastroenterology. 2014;146(1):85-95; Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J et al.

4

http://cp.mcafee.com/d/k-Kr410edEIcI6zAQsLThd79KVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqpJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle6o_ix_N7FT6hXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879LzC1PVEVsdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdK1VmL0U1gkKx

http://cp.mcafee.com/d/k-Kr4xEi6zqb3b1EVd7bZQjhOrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSOrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxLoQ9WuufjK1053TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejv7c3DPhOUrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrs8dlKCXF

http://cp.mcafee.com/d/k-Kr3xAp6wUSyMOMqejhO_t4QsCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddI6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUp-caj-k1WtN863TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejv7c3DPhOUrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrKlOa

http://cp.mcafee.com/d/k-Kr6xAq6jqb3b1EVd7bZQjhOrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QS-rhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxCkVRwfjK83TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejv7c3DPhOUrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOruDbA

http://cp.mcafee.com/d/1jWVIg3x0SyMOMqejhO_t4QsCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddK6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kU2aM-wZeU43TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejv7c3DPhOUrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrcgP72a8eEAGm

http://cp.mcafee.com/d/k-Kr4xASyMOMqejhO_t4QsCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddzzqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs5vH2sJgBguDs91EZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3ATNP0VYQsK6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcC-X4LPor_9Faf

http://cp.mcafee.com/d/avndxMO82hJ5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrudEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMmS6SJaIf7FT1oZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3ATNP0VYQsK6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCT3hUgXWeZypE

http://cp.mcafee.com/d/k-Kr3wUgdEIcI6zAQsLThd79KVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jpEVdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMNfVg9X6oZeUw5NXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879LzC1PVEVsdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdYuSdFyet

http://cp.mcafee.com/d/2DRPowd1MOd6Qm6m3hOqenXECzATsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJ6VJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle1df7FT5NXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879LzC1PVEVsdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdRb-9

http://cp.mcafee.com/d/avndxMw93gOrhopod79EVvKyqejtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQkjqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGsb_F7o3QXz8ZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3ATNP0VYQsK6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCYQR94XQ7

http://cp.mcafee.com/d/avndxNJ5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhpdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFN2Hp5LU01jKy-06svSo0pR03foAvCrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrIRoCw4VvSTwS

http://cp.mcafee.com/d/1jWVIq418idEIcI6zAQsLThd79KVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqb1J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle6qJAm_wfjK4xXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879InpsK-MrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOreqHFia7oal-C

http://cp.mcafee.com/d/5fHCN8edEIcI6zAQsLThd79KVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqbVJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle2LCvEbd-fjKcx8u-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or5SnbLI6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcC-qWw

http://cp.mcafee.com/d/2DRPoO92gOcCQm6m3hOqenXECzATsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJ5MSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD2_WhS0ZeUO4xXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879InpsK-MrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOr2kdX

http://cp.mcafee.com/d/k-Kr6zqb3b1EVd7bZQjhOrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSyedEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFM5qpS6JAioZeUwfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdyXbBTS3uQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6jocpQ

http://cp.mcafee.com/d/k-Kr6xEp418SyMOMqejhO_t4QsCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddEL6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUbumza1spB6Hp_P7FT2EZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3ASbIKnvodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdNcxfsp2CVfM

http://cp.mcafee.com/d/2DRPoArhopod79EVvKyqejtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQjhOrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxaFZli7DzQXwgbzTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejoKOVtZwTJ36GOxIOoaxgDjLgrdEFzAnTPob6Azh06gQp3zh02_R2k29Ew2IGjd40bYPbP1sQg1PvCy026PONEwsCjd41JxATNIKUSOPMvyw

http://cp.mcafee.com/d/avndygO86Qm6m3hOqenXECzATsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJeVJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle2-MRLUzQXz0Ofv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdyXbBTS3uQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6js-gawJs5bzVQ

http://cp.mcafee.com/d/FZsSczgs721J5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrjhdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMNI425oM7FT0k21XUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879InpsK-MrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrqDkN3vMw

http://cp.mcafee.com/d/5fHCNAgdEIcI6zAQsLThd79KVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqqpJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xyr9EVKOCOYrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOruA0XbMlJ

http://cp.mcafee.com/d/1jWVIgdEIcI6zAQsLThd79KVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqr9J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle6vz0DYBhWtMMfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdAQsTpjpudXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropd-EWq

http://cp.mcafee.com/d/avndy0Orhopod79EVvKyqejtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQS3qb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs9lfGGgYYuDs21su-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or9EVKOCOYrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrk-Ls

http://cp.mcafee.com/d/2DRPow82hJ5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrjvdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMjfflS0ZeU941XUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879ICzCXarbNLq6dlB3pAMl2xeDuwSrhj78LLCMmd96y0cxEO76y05_G4E4jh05pkCq80nVCnC2VEw3C_d404dDBzh0VcCq83r39JcvvfkK3CP9F

http://cp.mcafee.com/d/2DRPoA81MAd6Qm6m3hOqenXECzATsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJdMSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD1niuNBUZeUsfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdAQsTpjpudXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdHQQU

http://cp.mcafee.com/d/2DRPow821J5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrj76QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUp_mOfNBUZeUl7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCOqerIFIL6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCYEwh

http://cp.mcafee.com/d/k-Kr6h0SyMOMqejhO_t4QsCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddFL6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUdCa5qC9j51WtNwbzTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpd7dSkSnzuQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6juflnfJim

http://www.ncbi.nlm.nih.gov/pubmed/?term=Van%20Assche%20Switch%20to%20adalimumab%20in%20patients%20with%20Crohn%27s%20disease%20controlled%20by%20maintenance%20infliximab:%20prospective%20randomised%20SWITCH%20trial.

http://www.ncbi.nlm.nih.gov/pubmed/?term=Van%20Assche%20G%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Vermeire%20S%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Ballet%20V%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Gabriels%20F%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Noman%20M%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=D%27Haens%20G%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Claessens%20C%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Humblet%20E%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Vande%20Casteele%20N%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Gils%20A%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Gils%20A%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://www.ncbi.nlm.nih.gov/pubmed/?term=Rutgeerts%20P%5BAuthor%5D&cauthor=true&cauthor_uid=21948942

http://cp.mcafee.com/d/2DRPoQrhopod79EVvKyqejtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQPhOrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoCOqen63hOOOrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrvSBd

http://cp.mcafee.com/d/FZsSd39J5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrpKrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxzo84aNwfjK0E43TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpd7bz1EVppdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdLlcxPhMs

http://cp.mcafee.com/d/FZsS920Orhopod79EVvKyqejtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CSkjqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGsb_F7o3QXz8i7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCOqen63hOOOrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrliCJr3NM

http://cp.mcafee.com/d/2DRPow820Od6Qm6m3hOqenXECzATsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJBcSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD0JKp7_zewZeUm7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCOqen63hOOOrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrwSwy

http://cp.mcafee.com/d/avndzgs738srhopod79EVvKyqejtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CSmjqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs5ZxHvN7FT61XUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879ICzBNwQsIICZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCOgbi4mh2

http://cp.mcafee.com/d/5fHCNEgdEIcI6zAQsLThd79KVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jrb1J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle4GDRl8uufjK10Kfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdAQsKc6zBBATJ36GOxIOoaxgDjLgrdEFzAnTPob6Azh06gQp3zh02_R2k29Ew2IGjd40bYPbP1sQg1PvCy026PONEwsCjd41JxAT4nvM6CM

http://cp.mcafee.com/d/FZsS920Arhopod79EVvKyqejtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CSnPqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGscr12wZeUOd3TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpd7bz1EVppdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdwSEZiKtkMOnj

http://cp.mcafee.com/d/2DRPowd2gArhopod79EVvKyqejtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CSn3qb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs5mOKQ7FT6NXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879ICzBNwQsIICZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCNU6Qg75m

http://cp.mcafee.com/d/FZsS720sd21J5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrp76QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUnZ2ItazQXwI63TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpd7bz1EVppdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdZmFTrXWfuHpb

http://cp.mcafee.com/d/2DRPow86Qm6m3hOqenXECzATsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJBUSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD1n_7FT61XUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879ICzBNwQsIICZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCX_if7EKD

http://cp.mcafee.com/d/2DRPos838OcCQm6m3hOqenXECzATsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJAQsCQmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUpzZa7_4uDsp7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCOqen63hOOOrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOryT9K

http://cp.mcafee.com/d/FZsS93hJ5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqroKrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxuEufjK6zTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpd7bz1EVppdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdGN4_

http://cp.mcafee.com/d/FZsS93hJ5xBwQsCzB-W9EVdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqroKrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxuEufjK6zTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpd7bz1EVppdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdGN4_

http://cp.mcafee.com/d/2DRPowd6Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrohdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMbHjoOGfjKdzTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpd7bz1EVppdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdRoy8e-C8

http://cp.mcafee.com/d/1jWVIg3zqb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddI9CQmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUoS1mFcuDso7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCOqen63hOOOrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOr5QS1UTDX

http://cp.mcafee.com/d/5fHCN0SyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jr39J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle0pIuDs21XUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879ICzBNwQsIICZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcC-_vqJn-v

http://cp.mcafee.com/d/5fHCN8g418edEIcI6zAQsLTjKrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSMMrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxyvH4_xguDs2xXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879ICzBNwQsIICZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCTgQz0sl-

http://cp.mcafee.com/d/FZsS720Q86Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrovdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMT8-NcuDsi7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCOqen63hOOOrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOralgZ

http://cp.mcafee.com/d/FZsS938Arhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJxMSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD1roOaANWtN0u-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or9EVsod7bb9Lq6dlB3pAMl2xeDuwSrhj78LLCMmd96y0cxEO76y05_G4E4jh05pkCq80nVCnC2VEw3C_d404dDBzh0VcCq83r39LMpjr7Eh

http://cp.mcafee.com/d/1jWVIg4xESyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jr0USyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD18q6MQ61EZeWoZeUNdJ0IfjK4ERrm7Lz8BmaRoXfNWtN1KpeIhXUsrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrn1dU

Gastroenterology. 2012;142(2):257-65 e1-3. doi:10.1053/j.gastro.2011.10.032. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Sandborn WJ, van Assche G, Reinisch W, Colombel JF, D'Haens G, Wolf DC et al

Section: New Therapies Therapeutic Advances in Gastroenterology. 2015;8(2):66-82. Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases. Therapeutic advances in gastroenterology. Amiot A, Peyrin-Biroulet L.

Gastroenterology. 2014 Dec;147(6):1296-1307.e5. Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis. Adedokun OJ1, Sandborn WJ2, Feagan BG3, Rutgeerts P4, Xu Z5, Marano CW5, Johanns J5, Zhou H5,Davis HM5, Cornillie F6, Reinisch W7. New England Journal of Medicine. 2016;374:1754-1762. Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis. William J. Sandborn, M.D., Brian G. Feagan, M.D., Douglas C. Wolf, M.D., Geert D’Haens, M.D., Ph.D., Severine Vermeire, M.D., Ph.D., Stephen B. Hanauer, M.D., Subrata Ghosh, M.D., Heather Smith, M.B.A., Matthew Cravets, M.A., Paul A. Frohna, M.D., Ph.D., Richard Aranda, M.D., Sheila Gujrathi, M.D., and Allan Olson, M.D., for the TOUCHSTONE Study Group

New England Journal of Medicine. 2017 May 4;376(18):1723-1736. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. Sandborn WJ, Su C, Sands BE, D'Haens GR, Vermeire S, Schreiber S, Danese S, Feagan BG, Reinisch W, Niezychowski W, Friedman G, Lawendy N, Yu D, Woodworth D, Mukherjee A, Zhang H, Healey P, Panés J;

New England Journal of Medicine. 2016 Nov 17;375(20):1946-1960. Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P;

Section: Imaging/Diagnostics Gastroenterology. 2013 Jun;144 (7):1349-52, 1352.e1-6. doi: 10.1053/j.gastro.2013.04.008. Epub 2013 Apr 11. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Soetikno R1, Subramanian V, Kaltenbach T, Rouse RV, Sanduleanu S, Suzuki N, Tanaka S, McQuaid K.

Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148(3):639-51 e28. doi:10.1053/j.gastro.2015.01.031.

Section: Microbiome

Cell Host Microbe. 2014 Mar 12; 15(3):382-92. The treatment-naive microbiome in new-onset Crohn's disease. Gevers D1, Kugathasan S2, Denson LA3, Vázquez-Baeza Y4, Van Treuren W5, Ren B6, Schwager E6,Knights D7, Song SJ5, Yassour M1, Morgan XC6, Kostic AD1, Luo C1, González A5, McDonald D5,Haberman Y3, Walters T8, Baker S9, Rosh J10, Stephens

5

http://www.ncbi.nlm.nih.gov/pubmed/25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Adedokun%20OJ%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Sandborn%20WJ%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Feagan%20BG%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Rutgeerts%20P%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Xu%20Z%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Marano%20CW%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Johanns%20J%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Zhou%20H%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Davis%20HM%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Cornillie%20F%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Cornillie%20F%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://www.ncbi.nlm.nih.gov/pubmed/?term=Reinisch%20W%5BAuthor%5D&cauthor=true&cauthor_uid=25173754

http://cp.mcafee.com/d/5fHCN8q3x8SyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3joVMSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGDkHYV5ol02Dt5A0cEeDWGHIWNb018lcuurSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrU1L_

http://cp.mcafee.com/d/2DRPoQrhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FIsedEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMNnVOaMGfjK2NXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879ILLcIfcCZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCNAFvAUiX83Yt

http://cp.mcafee.com/d/5fHCN0p3x8edEIcI6zAQsLTjKrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSeudEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMMSgzGKMBI1WtMOfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdBZVBxVATJ36GOxIOoaxgDjLgrdEFzAnTPob6Azh06gQp3zh02_R2k29Ew2IGjd40bYPbP1sQg1PvCy026PONEwsCjd41JxATUQTjkUucgGX

http://cp.mcafee.com/d/avndz8A820srhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FIsqejqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs1mDP-13r4NWtMifv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdBZVBxVATJ36GOxIOoaxgDjLgrdEFzAnTPob6Azh06gQp3zh02_R2k29Ew2IGjd40bYPbP1sQg1PvCy026PONEwsCjd41JxAT51pSuYN

http://cp.mcafee.com/d/k-Kr3zqb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddLndEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMbGTjNWtMm6hXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879ILLcIfcCZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCQ5Vu

http://cp.mcafee.com/d/FZsS720w82hJ5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CTAjqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGscr11I_ZwSfjKc3TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpvupoupdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdDXf9

http://cp.mcafee.com/d/5fHCN0SyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jrOpJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle66NhIH8uDs63TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpvupoupdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropd_Zq1yZ2l

http://cp.mcafee.com/d/avndz8AcygArhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJVASyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD0DoqlQuDso7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCO-YOMYOrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrBiAOZm4v

http://cp.mcafee.com/d/avndy0Qrhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJVwSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD3tw7rSi0ZeU53TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpvupoupdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdNq68X-c-

http://cp.mcafee.com/d/2DRPoOrhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJVYSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgNdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCQvlK

http://cp.mcafee.com/d/k-Kr6zqb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddLe6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kU9up-d1WtMUu-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdOUiP

http://cp.mcafee.com/d/FZsS939J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CTxNJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle0FIzIOuQS0ZeUMfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCTQKd

http://cp.mcafee.com/d/k-Kr3zqb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddLf6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUe-5aM7FT2Ewfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCPOaX

http://cp.mcafee.com/d/2DRPoQ91MO76Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrud79J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle38Yip7y28Ebd-a5NDv5d7FT0UZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrkGEF

http://cp.mcafee.com/d/avndy0s83gArhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FIQsTdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMpS0ZeU9zXsvwfjK0EZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrDnq8

http://cp.mcafee.com/d/FZsS921J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CPhOyrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljwnY1WtNAu-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdzBvXjE53

http://cp.mcafee.com/d/avndxNJ5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CPhOCrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxyNcNF7UzQXzgZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrjv5t

http://cp.mcafee.com/d/FZsS81MA96Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrd7b9J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle0G4y9et1WtMUu-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropd_MCVjOvu99K8

http://cp.mcafee.com/d/avndzgA91MOrhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FIQsI6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUoH0yfjKc0gfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCRbnv94ybapvh

http://cp.mcafee.com/d/k-Kr6xEg43qb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddCzBYSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD0vqkGT4uDsr7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCMUCqemm63uQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6jun6-7LzM

http://cp.mcafee.com/d/k-Kr6xEg43qb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddCzBYSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD0vqkGT4uDsr7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCMUCqemm63uQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6jun6-7LzM

http://cp.mcafee.com/d/k-Kr41Ep6x0SyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jpEVsdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMS01S0ZeU32gZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrNbjg

http://cp.mcafee.com/d/5fHCNASyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jpEV76QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kU2GQDaMZeUw73TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejosjd7bb31Lq6dlB3pAMl2xeDuwSrhj78LLCMmd96y0cxEO76y05_G4E4jh05pkCq80nVCnC2VEw3C_d404dDBzh0VcCq83r39JrvlxGE-

http://cp.mcafee.com/d/k-Kr40UidEIcI6zAQsLTjKrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSqenzqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs5mWzQXygZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOre11oG3W

http://cp.mcafee.com/d/FZsS92hJ5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CPhOqejqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs4GM51UAOf44j_51WtN0u-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdQGa-

http://cp.mcafee.com/d/avndz8s938wrhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJ6ZPqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGsdS3GMQZ0uDse7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCMUCqemm63uQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6jraEvNkPEoime

http://cp.mcafee.com/d/2DRPosrhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJ6W9J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle2-AfyHI1WtMefv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcC_hwPftm4

http://cp.mcafee.com/d/avndyhJ5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQrFCQmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kU1tfDYq3QXwAu-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdLpDoOYry

http://cp.mcafee.com/d/2DRPoO739J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQrICQmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUpQHYhWtNwu-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdKWRaqxqvDBj6

http://cp.mcafee.com/d/k-Kr43qb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddETodEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMbHgCfjK10ZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOre2ngFRi

http://cp.mcafee.com/d/1jWVIg6wUe3zqb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddETvdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMNfRyvMEfjKdzTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejosjd7bb31Lq6dlB3pAMl2xeDuwSrhj78LLCMmd96y0cxEO76y05_G4E4jh05pkCq80nVCnC2VEw3C_d404dDBzh0VcCq83r39IDMFL0YhEwl7

M11, Heyman M12, Markowitz J13, Baldassano R14, Griffiths A15, Sylvester F16, Mack D17, Kim S18, Crandall W18, Hyams J16, Huttenhower C19, Knight R20, Xavier RJ21.

Nature. 2014 Jan 23; 505(7484):559-63. Diet rapidly and reproducibly alters the human gut microbiome. David LA1, Maurice CF2, Carmody RN2, Gootenberg DB2, Button JE2, Wolfe BE2, Ling AV3, Devlin AS4,Varma Y4, Fischbach MA4, Biddinger SB3, Dutton RJ2, Turnbaugh PJ2.

Selected Topics: Extraintestinal Manifestations

Gastroenterology & hepatology. 2013;10(10):585-95. Extraintestinal manifestations and complications in IBD. Nature reviews Ott C, Scholmerich J.

Selected topics: Pouch Surg Endosc. 2013 Nov; 27(11):4325-32. Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease. Zhu H1, Wu XR, Queener E, Kiran RP, Remzi FH, Shen B.

Gastroenterol Clin North Am. 2012 Jun; 41(2):355-78. Evaluating pouch problems. Li Y1, Shen B. Selected topics: Health Maintenance Gastroenterology Clinics of North America. 2012;41(2):325-37. Health maintenance in the inflammatory bowel disease patient. Sinclair JA, Wasan SK, Farraye FA. Selected topics: Epidemiology Gastroenterology. 2017 May 4. pii: S0016-5085(17)35554-3. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease. Singh H, Nugent Z, Yu BN, Lix LM, Targownik LE, Bernstein CN.

Selected topics: Postoperative Crohn’s

Gastroenterology. 2017 Jan; 152(1):271-275. American Gastroenterological Association Institute Guideline on the Management of Crohn's Disease After Surgical Resection. Nguyen GC, Loftus EV Jr, Hirano I, Falck-Ytter Y, Singh S, Sultan S;

Gastroenterology. 2017 Jan; 152(1):277-295.e3. doi: 10.1053/j.gastro.2016.10.039. Epub 2016 Nov 10. American Gastroenterological Association Institute Technical Review on the Management of Crohn's Disease After Surgical Resection. Regueiro M, Velayos F, Greer JB, Bougatsos C, Chou R, Sultan S, Singh S.

Gastroenterology. 2016 Jun; 150(7):1568-78. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, Plevy S, Popp J, Cornillie FJ, Lukas M, Danese S, Gionchetti P, Hanauer SB, Reinisch W, Sandborn WJ, Sorrentino D, Rutgeerts P

6

http://cp.mcafee.com/d/FZsS821J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQrK6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUb-mlS0ZeUSfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCMcfxIe5S

http://cp.mcafee.com/d/FZsS91MArhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJ6UUSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD3uNaRciCa3QXwgfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCRSUw

http://cp.mcafee.com/d/2DRPow73gs96Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhKYrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxDjQdFjol7FT1oZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrM68e

http://cp.mcafee.com/d/avndzgArhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJ6VEVdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMiz9RSkOt1WtN0u-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdBqrD4Mjd

http://cp.mcafee.com/d/k-Kr410SyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqadPqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGsc5zPfQDYhWtNsu-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdA9Xd

http://cp.mcafee.com/d/2DRPos738scCQm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhhhdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMTJyEZeUsfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCPfxt

http://cp.mcafee.com/d/k-Kr6xESyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqaapJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle0GiEZeUMfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxNcQsIIc6ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCRBB1iITy

http://cp.mcafee.com/d/1jWVIe41Eg6zqb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddEEICQmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUizI4dff7FT0ku-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1Or3ypEVpoodXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdJioJ5Fj5

http://cp.mcafee.com/d/k-Kr3wUp43qb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddEEI6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUbBJlEfjK10ZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrbYQyJA

http://cp.mcafee.com/d/k-Kr3wUp43qb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddEEI6QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUbBJlEfjK10ZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrbYQyJA

http://cp.mcafee.com/d/avndzhJ5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQknPqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs5SVP-1eFzUzQXygZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrvSUG

http://cp.mcafee.com/d/FZsS82gs86Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhhsdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFM5gAh9P7FT1oZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOr-JexWwDxVE

http://cp.mcafee.com/d/5fHCN0gdEIcI6zAQsLTjKrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSyyedEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFM3qpBYhWtMm10ZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3AS74PhOOMMrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrF7_a

http://cp.mcafee.com/d/avndz9J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQknzqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGsvFyfMJUZcigQP900cdCT7M0FThpdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropd_2RDlm51

http://cp.mcafee.com/d/1jWVIg418p6jqb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddEECzASyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD1SCp83QXxkg7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCMOOUCyedXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdGsT3AZctZscA

http://cp.mcafee.com/d/2DRPoOcy0w76Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhjKrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljxLmUOJUZeUAbzTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejoppsjh76ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCXYwX16fUKnRN

http://cp.mcafee.com/d/k-Kr418SyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqaq9J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle4JyHl0IfjK2Mofv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxBBNd4srSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrghCC

http://cp.mcafee.com/d/FZsS71MA82hJ5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQkQPqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs4GRDY27N8zQXxMOfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxBBNd4srSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrUOocXsMF

http://cp.mcafee.com/d/2DRPowd2gOrhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJ5dASyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD3bsVRwfjK10Qfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxBBNd4srSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrhZkFm1y3

http://cp.mcafee.com/d/k-Kr41Aq4x8SyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqar1J5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle0mFXLzQXz8Qfv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxBBNd4srSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrFzS4

http://cp.mcafee.com/d/k-Kr410i3x0SyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jqarVJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle2IE4hWtN0czTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejoppsjh76ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCW8fs

http://cp.mcafee.com/d/avndy0O86Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhjsdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFMtVA-k1WtN0o7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCMOOUCyedXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropd_o1i

http://cp.mcafee.com/d/avndxMAd6Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhj76QmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUcX5nhWtMefv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxBBNd4srSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrUBkr

http://cp.mcafee.com/d/FZsS93gAd21J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQkTzqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGsbOFoCgSNcuDsr41XUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879IcIK9EzzuQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6jtHg1PJZg97Gw

http://cp.mcafee.com/d/FZsS93gAd21J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CQkTzqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGsbOFoCgSNcuDsr41XUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879IcIK9EzzuQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6jtHg1PJZg97Gw

http://cp.mcafee.com/d/avndzgQ71Msrhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FJ5cQsCQmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUpAwxa17UzQXz0Ofv6h1KpeIhXUsQ40hrmVAWNeD5LSww2bqTcDm8GT90VdxBBNd4srSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrCuM8-tLx

http://cp.mcafee.com/d/2DRPoQd20s96Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhpKrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljwVKsWM7FT1o43TNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejoppsjh76ZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCZIf7zqX_

http://cp.mcafee.com/d/avndz8wcCQm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqrhphdEICzATvAm4TDNOb2pEVdTdw0Em8iW1WLgAjUzkPyPp1nQc9j-aFM9rz0xHp4CfjK5w87Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCMOOUCyedXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdKP8O

http://cp.mcafee.com/d/1jWVIq3xAgdEIcI6zAQsLTjKrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSUUrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoCOYe73DTzuQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6jsrJtThct

http://cp.mcafee.com/d/k-Kr4x0q4xESyMOMqejhO_teVKVJ5BxBMQsLTdEIIcK6zBOVJ5MsqekTQNNJ6XVEVvssuhjd-gzkN05mIXL00jtHeXM04TH1EVouuvvW_cThhvosWZOWqbyvfCzBdOXB-mKDp5dmXz7axVZicHs3jrwUSyOqejt-hojuv78I9CzATsS02xoxbE7GZ2hfydjebdA5vgMBfUGD0ijr7FT2UZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3ASnxMUs-YrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrRm13zgY030A-

http://cp.mcafee.com/d/5fHCN0idEIcI6zAQsLTjKrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSUYrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljw5r7FT0o5zTNAgrCjH4u-7d104mRKpeIjFNrZE80ySJP9RyaJOgejpu73xPXNLq6dlB3pAMl2xeDuwSrhj78LLCMmd96y0cxEO76y05_G4E4jh05pkCq80nVCnC2VEw3C_d404dDBzh0VcCq83r39LVF9hOeSHk_

http://cp.mcafee.com/d/5fHCN0idEIcI6zAQsLTjKrKrhpopsd7bZPqbb3bxEVsKrhs76zBdZcsrhK-qenT77AkPvA8Rcg1lHeXM04TqPKY01dWMqem7DDT-LPdQknS7eLsKCyUDPVEVjsKVvBHFShjlKUNOEuvkzaT0QSUqejqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs0Xv_3UzQXzgZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3ASnxMUs-YrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOr8zLx

http://cp.mcafee.com/d/avndzgw721J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CNRPqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs1kEX0uDs5xou-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1OrbMUsevudXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropdKHSy

http://cp.mcafee.com/d/avndy0srhopod79EVvKDsTsSyOMOUqenXCQmm6n3hOVsSyUed7arWoUSztYQsLKef8FC_8hGow2HmtTw09KRDtU02rRwQsIfffLZvCrEELIetuVtd5NfDPhOCVtO_bnjIyCHtNzBgY-F6lK1FIsyrhpd79K_8I9LfzAm4PhOrKr01gIgBQ3Rux8DN6FD5CO2LEoiDYljwnWEF8uDsn2UZYp46VAWN7LxPgg15JrCjH4Wsm_q208JHsOtoyHsA3ASnxMUs-YrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrX1Pb

http://cp.mcafee.com/d/FZsS91MOd6Qm6m3hOqenXFTdTdEIIcK6zB-VJ5BxBMQsKndEK3zhOC-CedETvd7bXzzOapLO4qC80GRDtU02rJpTu00CZod7b3PPX_nVCWabX3DnKnjhsjVYQsFKnsLORQX8FGTsoVkffGhBrwqr79CQmjhOrLOb2rPUV5xcQsCXCM0kb49t0ZnEi9YhGpNpIwHW64F_5kUo9_0uDsp7Lz8wTcDm8ZYeq208JHsOtoDjyTXgg15JrCjH4lrAwsCOYe73DTzuQcqHa6P9wG52teZ1ISyCehvvdwIqid40p3hAed40b_k9g8Cy0aOFcQg0LPcLc5Ph07d-q808rfb6y1OpcQg6S6jsG-5Xj8hc84N

http://cp.mcafee.com/d/k-Kr4wUp4zqb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddzCjqb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ34QTXTvjpdXgNGIErcC2Ek9QXQ6PqaoV5ZYS2NF8Qg1Ad6gUQg0LZgB0yq80HaAPh02_cOYMnd40sTVEw0xIYIq879APh0ropd-E8v

http://cp.mcafee.com/d/5fHCMUq43qb3b1EVd7bZQXCXCQmm6n3hO_sSyOMOUqenbCQn1NEVjvj76QrLCzBZNNV5cTV2dj40lqPKY01dSIXL00juI6zBxVVZ_HYPt55ZxPHTbFEK9Y-qekTbKnVqWtAkRrKcsG7DR8OJMddzC3qb9EVdTV5xdVYsyMCqejtPo0a5y4KwuHQ94-8RcUISglZ32k_yGs5p3QXwsu-cy3sOtozTMVE80ySJP9RytebvJ104mRKpeIhlKi1OqrZXLFICZEoRmkdCj1ka4WtW3pJ5csy--r1oQAq80O6z8sq80n-Eiwhd40lBipEw1vCpuobCy0erYQg0gSumd43AOpEwdIcCURAKzJ3T

http://cp.mcafee.com/d/2DRPosd21J5xBwQsCzB-WtPtPqbb3bxEVvKrhpopsd7bBPqbwUQsFLFzzqdTPhO-UUYyCrYx6Fy0aJpTu00CXmtTw09Lm3hOMYY-_R-pKyy-MVRXBQQn4-vd7arBTbYJteOaqJT6el3PWApmU6CNPVJ5AQsCXYyMCY-ehojd79KVI052N2ngflW4yv4qCsmr8a-xxavNle62vM7FT6hXUO8dP9Ryfv3Cww2bqTcDm9QUJ-Q40hrmVAWN5mV879FLTK-COrSxzlpgSpc5gEjFTEdCQkNObXVI5zihEw38qcxNEw1vWxa14Qg1ml9Cy05-pBVwKq80VLPh013pVoQgej9Cy0SMOrKw5c

crohn’s & colitis foundation visiting ibd · crohn’s & colitis foundation visiting ibd...

Documents